专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08955080B2 Managing single sign-ons between different entities 有权
标题翻译：管理不同实体之间的单一登录
公开(公告)号：US08955080B2
公开(公告)日：2015-02-10
申请号：US13708080
申请日：2012-12-07
申请人： Frank Brunswig , Peter Dell , Klaus Herter , Bare Said
发明人： Frank Brunswig , Peter Dell , Klaus Herter , Bare Said
IPC分类号： H04L29/06 , G06F21/41 , G06F21/31
CPC分类号： H04L63/0815 , G06F21/31 , G06F21/41 , H04L63/10
摘要： The disclosure generally describes computer-implemented methods, software, and systems for cloud-based single sign-on (SSO) capabilities. A computer-implemented method includes operations for identifying a first system for single sign-on capabilities, identifying a second system disparate from the first system for providing a single sign-on capability with the first system through a cloud-based SSO configuration manager, automatically accessing metadata associated with the sign-on information of the second system, the set of metadata identifying sign-on-related information for sharing at least one credential/certificate for logging in to the second system, using the metadata to obtain an authorization for a single sign-on between the first and second systems, receiving a request from the first system for authorization at the second system, and, in response to the request, providing the authorization and creating a cloud-based SSO system that includes the first and second systems.
摘要翻译：本公开一般描述了基于云的单点登录（SSO）功能的计算机实现的方法，软件和系统。计算机实现的方法包括用于识别用于单点登录能力的第一系统的操作，识别与第一系统不同的第二系统，用于通过基于云的SSO配置管理器自动地向第一系统提供单点登录能力访问与第二系统的登录信息相关联的元数据，所述元数据集合标识用于共享用于登录到第二系统的至少一个凭证/证书的登录相关信息，使用元数据来获得对于在第一和第二系统之间的单点登录，在第二系统接收来自第一系统的请求以进行授权，并且响应于该请求，提供授权并创建包括第一和第二系统的基于云的SSO系统系统。

2. 发明授权

US07868014B2 1-(hetero)aryl-3-amino-pyrrolidine derivatives for use as mGluR3 antagonists 有权
标题翻译：用作mGluR3拮抗剂的1-（杂）芳基-3-氨基 - 吡咯烷衍生物
公开(公告)号：US07868014B2
公开(公告)日：2011-01-11
申请号：US11576960
申请日：2005-10-13
申请人： Thomas Charles Britton , Veronique Dehlinger , Colin Peter Dell , Bruce Anthony Dressman , Jason Kenneth Myers , Eric Samuel Nisenbaum
发明人： Thomas Charles Britton , Veronique Dehlinger , Colin Peter Dell , Bruce Anthony Dressman , Jason Kenneth Myers , Eric Samuel Nisenbaum
IPC分类号： C07D401/04 , C07D409/04 , A61K31/506
CPC分类号： C07D417/14 , C07C45/41 , C07D207/14 , C07D401/04 , C07D403/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D417/04 , C07C47/55
摘要： The present invention relates to compounds of the Formula (I) which are useful for treating conditions associated with mGluR3 receptors, such as depression, schizophrenia and migraine, pharmaceutical compositions thereof, and methods of using the same.
摘要翻译：本发明涉及可用于治疗与mGluR3受体如抑郁症，精神分裂症和偏头痛相关的病症的式（I）化合物，其药物组合物及其使用方法。

3. 发明申请

US20080300266A1 1-(Hetero)Aryl-3-Amino-Pyrrolidine Derivatives for Use as Mglur3 Antagonists 有权
标题翻译：用作Mglur3拮抗剂的1-（异丁基）芳基-3-氨基 - 吡咯烷衍生物
公开(公告)号：US20080300266A1
公开(公告)日：2008-12-04
申请号：US11576960
申请日：2005-10-13
申请人： Thomas Charles Britton , Veronique Dehlinger , Colin Peter Dell , Bruce Anthony Dressman , Jason Kenneth Myers , Eric Samuel Nisenbaum
发明人： Thomas Charles Britton , Veronique Dehlinger , Colin Peter Dell , Bruce Anthony Dressman , Jason Kenneth Myers , Eric Samuel Nisenbaum
IPC分类号： A61K31/4439 , A61P25/06 , C07D401/04 , C07D207/14 , A61K31/427 , A61K31/4025 , A61K31/40 , C07D417/04 , C07D403/04 , A61K31/506
CPC分类号： C07D417/14 , C07C45/41 , C07D207/14 , C07D401/04 , C07D403/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D417/04 , C07C47/55
摘要： The present invention relates to compounds of the Formula (I) which are useful for treating conditions associated with mGluR3 receptors, such as depression, schizophrenia and migraine, pharmaceutical compositions thereof, and methods of using the same.
摘要翻译：本发明涉及可用于治疗与mGluR3受体如抑郁症，精神分裂症和偏头痛相关的病症的式（I）化合物，其药物组合物及其使用方法。

4. 发明授权

US5663375A Pharmaceutical compounds 失效
标题翻译：药物化合物
公开(公告)号：US5663375A
公开(公告)日：1997-09-02
申请号：US293786
申请日：1994-08-22
申请人： Michael Brunavs , Colin Peter Dell , Peter Thaddeus Gallagher , William Martin Owton , Colin William Smith
发明人： Michael Brunavs , Colin Peter Dell , Peter Thaddeus Gallagher , William Martin Owton , Colin William Smith
IPC分类号： A61K31/35 , A61K31/352 , A61K31/36 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/44 , A61K31/443 , A61K31/4433 , A61P1/16 , A61P3/10 , A61P9/10 , A61P19/02 , A61P29/00 , A61P35/00 , A61P37/00 , A61P37/02 , A61P37/06 , A61P43/00 , C07D311/92 , C07D405/04 , C07D407/04 , C07D409/04 , C07D215/00 , C07D333/62 , C07D409/00
CPC分类号： C07D405/04 , A61K31/35 , A61K31/36 , A61K31/38 , A61K31/40 , A61K31/44 , C07D311/92 , C07D407/04 , C07D409/04
摘要： Pharmaceutical compounds of the formula ##STR1## in which n is 0, 1 or 2 and R.sup.1 is attached at any of the positions 7, 8, 9 or 10, and each R.sup.1 is halo, carboxy, trifluoromethyl, hydroxy, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, C.sub.1-4 alkylthio, hydroxy-C.sub.1-4 alkyl, hydroxy-C.sub.1-4 alkoxy, nitrogen-containing heterocyclyl, nitro, trifluoromethoxy, --COOR.sup.5 where R.sup.5 is an ester group, --COR.sup.6, --CONR.sup.6 R.sup.7 or --NR.sup.6 R.sup.7 where R.sup.6 and R.sup.7 are each hydrogen or C.sub.1-4 alkyl;R.sup.2 is phenyl, naphthyl or heteroaryl selected from thienyl, pyridyl, benzothienyl, quinolinyl, benzofuranyl or benzimidazolyl, said phenyl, naphthyl and heteroaryl groups being optionally substituted, or R.sup.2 is furanyl optionally substituted with C.sub.1-4 alkyl;R.sup.3 is nitrile, carboxy, --COOR.sup.8 where R.sup.8 is an ester group, or --CONR.sup.9 R.sup.10 where R.sup.9 and R.sup.10 are each hydrogen or C.sub.1-4 alkyl; andR.sup.4 is --NR.sup.11 R.sup.12, --NR.sup.11 COR.sup.12, --N(COR.sup.11).sub.2 or --N.dbd.CHOCH.sub.2 R.sup.11 where R.sup.11 and R.sup.12 are each hydrogen or C.sub.1-4 alkyl optionally substituted with carboxy, --N.dbd.CH--NR.sup.13 R.sup.14 where R.sup.13 is hydrogen or C.sub.1-4 alkyl and R.sup.14 is C.sub.1-4 alkyl, optionally substituted phenyl or optionally substituted heteroaryl, ##STR2## where X is C.sub.2-4 alkylene, or --NHSO.sub.2 R.sup.15 where R.sup.15 is C.sub.1-4 alkyl, trifluoromethyl or optionally substituted phenyl; and salts thereof.
摘要翻译：其中n为0,1或2并且R 1连接在7,8,9或10位的任何位置的式“IMAGE”的药物化合物，并且每个R 1为卤素，羧基，三氟甲基，羟基，C 1-4烷基 C 1-4烷氧基，C 1-4烷硫基，羟基-C 1-4烷基，羟基-C 1-4烷氧基，含氮杂环基，硝基，三氟甲氧基，-COOR 5，其中R5是酯基，-COR6，-CONR6R7或 - NR 6 R 7，其中R 6和R 7各自为氢或C 1-4烷基; R 2是选自噻吩基，吡啶基，苯并噻吩基，喹啉基，苯并呋喃基或苯并咪唑基的苯基，萘基或杂芳基，所述苯基，萘基和杂芳基任选被取代，或R 2是任选被C 1-4烷基取代的呋喃基; R3是腈，羧基，-COOR8，其中R8是酯基，或-CONR9R10，其中R9和R10各自是氢或C1-4烷基; 并且R 4为-NR 11 R 12，-NR 11 COR 12，-N（COR 11）2或-N = CHOCH 2 R 11，其中R 11和R 12各自为氢或任选被羧基取代的C 1-4烷基，-N = CH-NR 13 R 14，其中R 13为氢或C1- 4烷基和R 14是C 1-4烷基，任选取代的苯基或任选取代的杂芳基，其中X是C 2-4亚烷基或-NHSO 2 R 15，其中R 15是C 1-4烷基，三氟甲基或任选取代的苯基; 及其盐。

5. 发明申请

US20140165150A1 CONFIGURING AND MONITORING A SINGLE SIGN-ON SYSTEM 有权
标题翻译：配置和监控单点登录系统
公开(公告)号：US20140165150A1
公开(公告)日：2014-06-12
申请号：US13708080
申请日：2012-12-07
申请人： Frank Brunswig , Peter Dell , Klaus Herter , Bare Said
发明人： Frank Brunswig , Peter Dell , Klaus Herter , Bare Said
IPC分类号： H04L29/06 , G06F21/41
CPC分类号： H04L63/0815 , G06F21/31 , G06F21/41 , H04L63/10
摘要： The disclosure generally describes computer-implemented methods, software, and systems for cloud-based single sign-on (SSO) capabilities. A computer-implemented method includes operations for identifying a first system for single sign-on capabilities, identifying a second system disparate from the first system for providing a single sign-on capability with the first system through a cloud-based SSO configuration manager, automatically accessing metadata associated with the sign-on information of the second system, the set of metadata identifying sign-on-related information for sharing at least one credential/certificate for logging in to the second system, using the metadata to obtain an authorization for a single sign-on between the first and second systems, receiving a request from the first system for authorization at the second system, and, in response to the request, providing the authorization and creating a cloud-based SSO system that includes the first and second systems.
摘要翻译：本公开一般描述了基于云的单点登录（SSO）功能的计算机实现的方法，软件和系统。计算机实现的方法包括用于识别用于单点登录能力的第一系统的操作，识别与第一系统不同的第二系统，用于通过基于云的SSO配置管理器自动地向第一系统提供单点登录能力访问与第二系统的登录信息相关联的元数据，所述元数据集合标识用于共享用于登录到第二系统的至少一个凭证/证书的登录相关信息，使用元数据来获得对于在第一和第二系统之间的单点登录，在第二系统接收来自第一系统的请求以进行授权，并且响应于该请求，提供授权并创建包括第一和第二系统的基于云的SSO系统系统。

6. 发明申请

US20110161342A1 BUSINESS OBJECT NODE ACCESS MANAGEMENT FOR SEARCH SERVICES IN A SERVICE-ORIENTED ARCHITECTURE 审中-公开
标题翻译：业务对象节点访问管理在面向服务的架构中搜索服务
公开(公告)号：US20110161342A1
公开(公告)日：2011-06-30
申请号：US12647755
申请日：2009-12-28
申请人： Lambert Boskamp , Cristina Buchholz , Peter Dell , Wolfgang Koch , Markus Viol , Jens Weiler
发明人： Lambert Boskamp , Cristina Buchholz , Peter Dell , Wolfgang Koch , Markus Viol , Jens Weiler
IPC分类号： G06F17/30
CPC分类号： G06F16/2455 , G06F16/2445
摘要： A system may include a database comprising stored data and a business process platform including business object metadata defining business objects representing the stored data. The business process platform may receive a query from a user to retrieve data from a first business object node of a business object, the business object representing stored data, determine whether the user is authorized to traverse all associations of a SELECT list of the query, determine whether the user is authorized to traverse all associations of a WHERE clause of the query, determine whether the user is authorized to retrieve any instances of each business object node of column specifications of the SELECT list of the query, and, if the determinations are affirmative, executing the query to retrieve a first result set.
摘要翻译：系统可以包括包括存储的数据的数据库和业务处理平台，其包括业务对象元数据，其定义表示存储的数据的业务对象。业务处理平台可以接收来自用户的查询以从业务对象的第一业务对象节点检索数据，业务对象表示存储的数据，确定用户是否被授权遍历查询的SELECT列表的所有关联，确定用户是否被授权遍历查询的WHERE子句的所有关联，确定用户是否被授权检索查询的SELECT列表的列规范的每个业务对象节点的任何实例，如果确定是肯定地执行查询以检索第一结果集。

7. 发明授权

US07148236B2 Modulators of acetylcholine receptors 失效
标题翻译：乙酰胆碱受体的调节剂
公开(公告)号：US07148236B2
公开(公告)日：2006-12-12
申请号：US10500516
申请日：2002-07-29
申请人： Peter Charles Astles , Stephen Richard Baker , Rowena Villanueva Cube , Jose Antonio Martinez-Perez , Ana Isabel Mateo Herranz , Jean Michel Vernier , Colin Peter Dell , Sonia Gutierrez , Lourdes Prieto , Martine Keenan , Adam Jan Sanderson , Colin William Smith
发明人： Peter Charles Astles , Stephen Richard Baker , Rowena Villanueva Cube , Jose Antonio Martinez-Perez , Ana Isabel Mateo Herranz , Jean Michel Vernier , Colin Peter Dell , Sonia Gutierrez , Lourdes Prieto , Martine Keenan , Adam Jan Sanderson , Colin William Smith
IPC分类号： A01N43/42 , A61K31/44 , C07D451/02 , C07D451/04 , C07D451/06
CPC分类号： A61K31/46 , A61K31/55 , C07D451/04 , C07D451/14
摘要： The present invention relates to compounds that modulate neurotransmission by promoting the release of neurotransmitters such as acetylcholine, dopamine and norepinephrine. More particularly, the present invention relates to thio-bridged aryl compounds that are capable of modulating acetylcholine receptors and pharmaceutical compositions comprising such compounds. The compounds disclosed are useful for the treatment of dysfunctions of the central and autonomic nervous systems.
摘要翻译：本发明涉及通过促进神经递质如乙酰胆碱，多巴胺和去甲肾上腺素的释放来调节神经传递的化合物。更具体地，本发明涉及能够调节乙酰胆碱受体的硫代桥连芳基化合物和包含这些化合物的药物组合物。所公开的化合物可用于治疗中枢神经系统和自主神经系统的功能障碍。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式